SRX-246

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameSRX-246
Drug Alias NameSRX-246API 246
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVasopressin V1a receptor antagonists
TargetsVasopressin V1a receptor
Therapy Area/IndicationsStress Disorders, Post-TraumaticDisruptive, Impulse Control, and Conduct DisordersFear +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAzevan
China Registration ClassN/A

Develop Information

Active CompaniesAzevan Pharmaceuticals Inc
Inactive CompaniesNational Institute Of Mental Health (Nimh)
Active IndicationsFragile X Syndrome
Inactive IndicationsStress Disorders, Post-TraumaticDisruptive, Impulse Control, and Conduct DisordersFear +[6] 

Other Information

ATC CodeN/A
Related LinksWikipedia